Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 19/20 | 0.67 |
| ▸ | CA1 | P00915 | 18/20 | 0.67 |
| ▸ | MMP1 | P03956 | 4/20 | 0.67 |
| ▸ | MMP2 | P08253 | 4/20 | 0.67 |
| ▸ | MMP9 | P14780 | 4/20 | 0.67 |
| ▸ | MMP8 | P22894 | 4/20 | 0.67 |
| ▸ | MMP13 | P45452 | 4/20 | 0.67 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20473121 | 1.00 | CA2 (0.67) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL7797690 | 1.00 | CA2 (0.67) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL20473120 | 0.97 | CA2 (0.64) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL899196 | 0.97 | CA2 (0.65) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3435260 | 0.95 | CA2 (0.62) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL20476642 | 0.95 | CA2 (0.62) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2511858 | 0.92 | CA2 (0.60) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2512376 | 0.92 | CA2 (0.60) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2516323 | 0.92 | CA2 (0.60) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3434755 | 0.92 | CA2 (0.60) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8563787-B2 | Preparation of homoallyl alcohols in the presence of noncovalently supported ionic liquid phase catalysts under gas-phase reaction conditions | BASF SE (DE) | 2013-10-22 | — | — | US | disclosed |
| US-20120083630-A1 | PREPARATION OF HOMOALLYL ALCOHOLS IN THE PRESENCE OF NONCOVALENTLY SUPPORTED IONIC LIQUID PHASE CATALYSTS UNDER GAS-PHASE REACTION CONDITIONS | BASF SE (DE) | 2012-04-05 | — | — | US | disclosed |
| US-7999449-B2 | Electroconductive polymer electrode and actuator using the same | EAMEX CORPORATION (JP) | 2011-08-16 | — | — | US | disclosed |
| US-20070254216-A1 | Electroconductive Polymer Electrode and Actuator Using the Same | EAMEX CORPORATION (JP) | 2007-11-01 | — | — | US | disclosed |
| US-20070119716-A1 | Filmy object of conductive polymer | EAMEX CORPORATION (JP) | 2007-05-31 | — | — | US | disclosed |
| EP-1768247-A1 | ELECTROCONDUCTIVE POLYMER ELECTRODE AND ACTUATOR USING THE SAME | Eamex Corporation (JP) | 2007-03-28 | — | — | EP | disclosed |
| EP-1712579-A1 | FILMY OBJECT OF CONDUCTIVE POLYMER | Eamex Corporation (JP) | 2006-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083630-A1 | PREPARATION OF HOMOALLYL ALCOHOLS IN THE PRESENCE OF NONCOVALENTLY SUPPORTED IONIC LIQUID PHASE CATALYSTS UNDER GAS-PHASE REACTION CONDITIONS | ADH1A, ADH1C, MGLL | CA2 4090/4885CA1 3307/4885MMP1 3747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.